Pay in 4 interest-free payments of $7.38 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
In the SURMOUNT-1 clinical trial, participants lost approximately 15-20% of their body weight over 72 weeks, with results varying by dose
Women often notice: Increased abdominal fat, even without changes in diet Slower metabolism and reduced calorie burning Increased insulin resistance Loss of muscle mass Persistent hunger and cravings Difficulty sleeping, which further affects weight regulation These changes are rooted in biology, not willpower
Tirzepatide promotes weight loss by empowering you to eat less calories on a daily basis
They aid in weight loss, which can be particularly beneficial for people with inflammatory arthritis who struggle with obesity or diabetes
With semaglutide-delayed gastric emptying, this window may need to be even longer, up to 5 hours for some people
